AC
VC

Agent Capital

Boston, United Statesagentcapital.com

Agent Capital is a venture capital firm based in Boston, the United States, investing in Healthcare & Life Sciences, Oncology and Immunology, 41 tracked investments.

41
Investments Tracked

About Agent Capital

Agent Capital is a venture capital firm headquartered in Boston, the United States. We have recorded 41 investments for Agent Capital to date.

Sector activity concentrates in Healthcare & Life Sciences, Oncology, Immunology and Personalized Medicine. Coverage extends to 8 sectors in total. Participation spans Series A, Series B and Series C+ rounds.

Agent Capital is a venture capital firm that invests in early-stage healthcare and life science companies. They focus on novel therapeutics, diagnostics, and medical devices.

Investment Focus

Stage Focus
series-aseries-bseries-c-plus
Sectors
Healthcare & Life SciencesoncologyimmunologyPersonalized Medicinerare diseasebiotechnologytherapeuticsHealthcare Tech

Investment Thesis

Agent Capital is a venture capital firm that invests in early-stage healthcare and life science companies. They focus on novel therapeutics, diagnostics, and medical devices.

Agent Capital Portfolio Companies

24 of 36 tracked holdings.

Portfolio outcomes
29 active4 acquired1 stalled10.3% exit rate

Team

Geeta VemuriManaging Partner, Founder

Dr. Geeta Vemuri is Founder and Managing Partner at Agent Capital. Geeta leads and oversees all Agent Capital activities, including portfolio management, new investments and operation activities.

Preston NoonPartner, Co-Founder

Dr. Preston Noon is Co-Founder and Partner at Agent Capital. Preston supports all Agent Capital fund activities, including leading new investments, portfolio management, and maintaining back-office functions.

Anthony DiNataleVice President

Dr. Anthony DiNatale is a Vice President at Agent Capital and supports new investments and portfolio management. Anthony is also supporting Agent Capital portfolio company Cantai Therapeutics as Associate Director of Operations.

Kirti NimmalaInvestment Analyst

Kirti Nimmala is an Investment Analyst at Agent Capital and supports portfolio management and due diligence for new investments.

Venkata Aditya KalagaInvestment Analyst

Venkata Aditya Kalaga holds a Master of Technology Management from UC Santa Barbara and a Bachelor of Dental Surgery from NTR University of Health Sciences.

Bruce PeacockOperating Partner

Mr. Bruce A. Peacock, CPA, serves as a Venture Partner at Agent Capital, and as Executive Chairman at Carisma Therapeutics.

John OrloffVenture Partner

Dr. John Orloff joins Agent Capital following his position as EVP and Global Head of R&D for Alexion, where his leadership in expanding the development pipeline from three to 30 programs supported the recent $39 billion acquisition of Alexi…

John GlasspoolVenture Partner

Mr. R. John Glasspool serves as a Venture Partner at Agent Capital, and has over 25 years of deep commercial industry expertise throughout the BioPharma industry.

Julie GionfriddoHead of Investor Relations and Fundraising

Julie Gionfriddo joined Agent Capital in 2023 as Head of Investor Relations and Fundraising. She has 20+ years of VC and PE experience including fundraising, new investments, investor relations, and marketing.

Marla McMillanVP of Fund Finance
Lisa KraeutlerVP of Fund Finance
Lori ForrestController

Explore Agent Capital's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in United States

Other Investors in Healthcare & Life Sciences / Oncology